<DOC>
	<DOC>NCT00683332</DOC>
	<brief_summary>The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.</brief_summary>
	<brief_title>Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)</brief_title>
	<detailed_description>Three-thousand or 10% of total number of patients given tigecycline will be included in the study</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>All patients from the study center who received or will receive at least one dose of Tygacil according to the approved product indication. Previously discontinued Tygacil therapy due to significant safety concern.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Observational study</keyword>
	<keyword>Tigecycline</keyword>
	<keyword>infection</keyword>
	<keyword>skin</keyword>
	<keyword>abdominal</keyword>
</DOC>